M Vermalle1,2, M Alessandrini3, T Graillon4, N C Paladino5, K Baumstarck3, F Sebag5, H Dufour4, T Brue1,2, F Castinetti6,7. 1. Aix-Marseille Université, Institut National de la Santé et de la Recherche Médicale (INSERM), U1251, Marseille Medical Genetics (MMG), Marseille, France. 2. Department of Endocrinology, Hôpital de la Conception, Assistance Publique - Hôpitaux de Marseille (AP-HM), Centre de Référence des Maladies Rares Hypophysaires HYPO 13005, Marseille, France. 3. Aix Marseille University, Marseille, France. 4. Department of endocrine surgery, La Conception Hospital, Marseille, France. 5. Department of Neurosurgery, La Timone Hospital, Marseille, France. 6. Aix-Marseille Université, Institut National de la Santé et de la Recherche Médicale (INSERM), U1251, Marseille Medical Genetics (MMG), Marseille, France. frederic.castinetti@ap-hm.fr. 7. Department of Endocrinology, Hôpital de la Conception, Assistance Publique - Hôpitaux de Marseille (AP-HM), Centre de Référence des Maladies Rares Hypophysaires HYPO 13005, Marseille, France. frederic.castinetti@ap-hm.fr.
Abstract
INTRODUCTION: Hypercortisolism leads to severe clinical consequences persisting after the onset of remission. These physical sequelae of cortisol exposure are known to profoundly impact the patient's quality of life. As psychological factors may be correlated with this quality of life, our objective was to determine the specific weight of psychological determinants of quality of life in patients in remission from hypercortisolism. PATIENTS AND METHODS: In an observational study, 63 patients with hypercortisolism in remission were asked to complete exhaustive self-administered questionnaires including quality of life (WHOQoL-BREF and Cushing QoL), depression, anxiety, self-esteem, body image, and coping scales. Multivariate analyses were performed. Psychological variables relevant to the model were: anxiety, depression, self-esteem, body image, and positive thinking dimension of the Brief-COPE. Cortisol deficiency was defined as a potential confounder. RESULTS: The median time since remission was 3 years. Patients had significantly lower quality of life and body satisfaction score than the French population and patients with chronic diseases. Depression significantly impaired all WHOQoL and Cushing QoL domains. A low body satisfaction score significantly impaired social relationships quality of life score. In total, 42.9% of patients still needed working arrangements, 19% had disability or cessation of work. CONCLUSION: Patients in biological remission of hypercortisolism can rarely be considered as functionally cured: this is evidenced by altered quality of life, working arrangements, and chronic depression. A multidisciplinary management of these patients is thus mandatory on a long-term basis.
INTRODUCTION:Hypercortisolism leads to severe clinical consequences persisting after the onset of remission. These physical sequelae of cortisol exposure are known to profoundly impact the patient's quality of life. As psychological factors may be correlated with this quality of life, our objective was to determine the specific weight of psychological determinants of quality of life in patients in remission from hypercortisolism. PATIENTS AND METHODS: In an observational study, 63 patients with hypercortisolism in remission were asked to complete exhaustive self-administered questionnaires including quality of life (WHOQoL-BREF and Cushing QoL), depression, anxiety, self-esteem, body image, and coping scales. Multivariate analyses were performed. Psychological variables relevant to the model were: anxiety, depression, self-esteem, body image, and positive thinking dimension of the Brief-COPE. Cortisol deficiency was defined as a potential confounder. RESULTS: The median time since remission was 3 years. Patients had significantly lower quality of life and body satisfaction score than the French population and patients with chronic diseases. Depression significantly impaired all WHOQoL and Cushing QoL domains. A low body satisfaction score significantly impaired social relationships quality of life score. In total, 42.9% of patients still needed working arrangements, 19% had disability or cessation of work. CONCLUSION:Patients in biological remission of hypercortisolism can rarely be considered as functionally cured: this is evidenced by altered quality of life, working arrangements, and chronic depression. A multidisciplinary management of these patients is thus mandatory on a long-term basis.
Authors: Olaf M Dekkers; Erzsébet Horváth-Puhó; Jens Otto L Jørgensen; Suzanne C Cannegieter; Vera Ehrenstein; Jan P Vandenbroucke; Alberto M Pereira; Henrik Toft Sørensen Journal: J Clin Endocrinol Metab Date: 2013-03-26 Impact factor: 5.958
Authors: Jessica K Lambert; Levana Goldberg; Sofia Fayngold; Jane Kostadinov; Kalmon D Post; Eliza B Geer Journal: J Clin Endocrinol Metab Date: 2013-02-07 Impact factor: 5.958
Authors: Elena Valassi; Iacopo Chiodini; Richard A Feelders; Cornelie D Andela; Margueritta Abou-Hanna; Sarah Idres; Antoine Tabarin Journal: Endocr Connect Date: 2022-06-24 Impact factor: 3.221
Authors: A S Šojat; B Dunjić-Kostić; L V Marina; M Ivović; N V Radonjić; A Kendereški; A Ćirković; M Tančić-Gajić; Z Arizanović; S Mihajlović; S Vujović Journal: J Endocrinol Invest Date: 2021-02-02 Impact factor: 4.256
Authors: Karol Piotr Sagan; Elżbieta Andrysiak-Mamos; Ernest Tyburski; Leszek Michał Sagan; Anhelli Syrenicz Journal: J Clin Med Date: 2021-04-26 Impact factor: 4.241
Authors: Roberta Armignacco; Anne Jouinot; Lucas Bouys; Amandine Septier; Thomas Lartigue; Mario Neou; Cassandra Gaspar; Karine Perlemoine; Leah Braun; Anna Riester; Fidéline Bonnet-Serrano; Anne Blanchard; Laurence Amar; Carla Scaroni; Filippo Ceccato; Gian Paolo Rossi; Tracy Ann Williams; Casper K Larsen; Stéphanie Allassonnière; Maria-Christina Zennaro; Felix Beuschlein; Martin Reincke; Jérôme Bertherat; Guillaume Assié Journal: Eur J Endocrinol Date: 2022-01-13 Impact factor: 6.664